Capital composition 1
Parent company financial statementsBalance sheet - assets 2
Balance sheet - liabilities 3
Statement of operations 4
Statement of comprehensive income (loss) 5
Statement of cash flows 6
Statement of changes in equityStatement of changes in equity - 1/1/2016 to 6/30/2016 7
Statement of changes in equity - 1/1/2015 to 6/30/2015 8
Statement of value added 9
Consolidated financial statementsBalance sheet - assets 10
Balance sheet - liabilities 11
Statement of operations 12
Statement of comprehensive income (loss) 13
Statement of cash flows 14
Statement of changes in equityStatement of changes in equity - 1/1/2016 to 6/30/2016 15
Statement of changes in equity - 1/1/2015 to 6/30/2015 16
Statement of value added 17
Comments on performance 18
Notes to the quarterly information 29
Opinions and statementsSpecial Review Report - Unqualified 70
Officers' Statement on the Financial Statements 72
Officers' Statement on the Independent Auditor's Report 73
Company information/capital composition
Number of shares (Units) | Current quarter 6/30/2016 |
Paid-up capital | |
Common | 113,081,127 |
Preferred | 0 |
Total | 113,081,127 |
Treasury shares | |
Common | 0 |
Preferred | 0 |
Total | 0 |
Code | Description | Current quarter 6/30/2016 | Prior year 12/31/2015 |
1 | Total assets | 1,377,885 | 1,454,578 |
1.01 | Current assets | 69,256 | 42,899 |
1.01.01 | Cash and cash equivalents | 26,669 | 1,108 |
1.01.03 | Trade receivables | 462 | 1,167 |
1.01.03.02 | Other receivables | 462 | 1,167 |
1.01.03.02.01 | Commercial agreements | 462 | 1,167 |
1.01.06 | Taxes recoverable | 13,659 | 342 |
1.01.06.01 | Current taxes recoverable | 13,659 | 342 |
1.01.07 | Prepaid expenses | 1,517 | 279 |
1.01.07.01 | Advances to suppliers | 0 | 4 |
1.01.07.02 | Prepaid expenses | 1,517 | 275 |
1.01.08 | Other current assets | 26,949 | 40,003 |
1.01.08.03 | Other | 26,949 | 40,003 |
1.01.08.03.01 | Related parties | 2,542 | 1,781 |
1.01.08.03.01 | Other assets | 24,407 | 8,210 |
1.01.08.03.01 | Derivatives | 0 | 30,012 |
1.02 | Non-current assets | 1,308,629 | 1,411,679 |
1.02.01 | Long-term receivables | 37,949 | 76,067 |
1.02.01.08 | Receivables from related parties | 6,917 | 16,339 |
1.02.01.09 | Other non-current assets | 31,032 | 59,728 |
1.02.01.09.04 | Other assets | 25,546 | 39,349 |
1.02.01.09.05 | Tax and social security credits | 5,486 | 20,379 |
1.02.02 | Investments | 1,124,972 | 1,184,311 |
1.02.02.01 | Equity interests | 1,124,972 | 1,184,311 |
1.02.02.01.02 | Interests in subsidiaries | 1,124,972 | 1,184,311 |
1.02.03 | Property and equipment | 2,020 | 2,488 |
1.02.03.01 | Property and equipment in use | 2,020 | 2,488 |
1.02.04 | Intangible assets | 143,688 | 148,813 |
1.02.04.01 | Intangible assets | 143,688 | 148,813 |
Code | Description | Current quarter 6/30/2016 | Prior year 12/31/2015 |
2 | Total liabilities | 1,377,885 | 1,454,578 |
2.01 | Current liabilities | 448,123 | 808,639 |
2.01.01 | Social and labor liabilities | 6,794 | 9,748 |
2.01.01.02 | Labor liabilities | 6,794 | 9,748 |
2.01.03 | Tax liabilities | 179 | 155 |
2.01.03.01 | Federal tax liabilities | 179 | 155 |
2.01.03.01.02 | Other federal taxes payable | 179 | 155 |
2.01.04 | Borrowings | 424,186 | 780,933 |
2.01.04.01 | Borrowings | 373,868 | 431,647 |
2.01.04.01.01 | In local currency | 373,868 | 334,874 |
2.01.04.01.02 | In foreign currency | 0 | 96,773 |
2.01.04.02 | Debentures | 50,318 | 349,286 |
2.01.05 | Other liabilities | 16,964 | 17,803 |
2.01.05.01 | Payables to related parties | 2,121 | 2,322 |
2.01.05.01.02 | Payables to subsidiaries | 2,121 | 2,322 |
2.01.05.02 | Other | 14,843 | 15,481 |
2.01.05.02.04 | Other payables | 14,843 | 15,481 |
2.02 | Non-current liabilities | 164,998 | 101,577 |
2.02.01 | Borrowings | 17,705 | 15,745 |
2.02.01.01 | Borrowings | 17,705 | 15,745 |
2.02.01.01.01 | In local currency | 17,705 | 15,745 |
2.02.02 | Other liabilities | 147,247 | 85,773 |
2.02.02.01 | Payables to related parties | 137,473 | 66,771 |
2.02.02.01.02 | Payables to subsidiaries | 137,473 | 66,771 |
2.02.02.02 | Other | 9,774 | 19,002 |
2.02.02.02.04 | Provision for net capital deficiency | 9,774 | 19,002 |
2.02.03 | Deferred taxes | 16 | 16 |
2.02.03.01 | Deferred income tax and social contribution | 16 | 16 |
2.02.04 | Provision | 30 | 43 |
2.02.04.01 | Provision for tax, social security, labor and civil contingencies | 30 | 43 |
2.03 | Equity | 764,764 | 544,362 |
2.03.01 | Paid-up capital | 2,187,126 | 1,792,657 |
2.03.02 | Capital reserves | -56,698 | 167,970 |
2.03.02.07 | Goodwill on capital transactions | -56,698 | 167,970 |
2.03.04 | Revenue reserves | 0 | 273 |
2.03.04.01 | Legal reserve | 0 | 273 |
2.03.05 | Retained earnings (accumulated deficit) | -1,365,664 | -1,416,538 |
Brasil Pharma SA published this content on 14 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 September 2016 13:05:04 UTC.
Original documenthttp://ri.brasilpharma.com.br/Download.aspx?Arquivo=Iy5opqVthoPkg2r7eRiMZA==
Public permalinkhttp://www.publicnow.com/view/9725BFD0E1B4D41F232CD16EDB31EFF097D61E00